New insights in congenital diaphragmatic hernia

Current Respiratory Medicine Reviews

Volumn 4, Issue 3, 2008, Pages 157-173

  Boucherat, Olivier ^a,b,c   Benachi, Alexandra ^a,b,d   Storme, Laurent ^e,f   Bourbon, Jacques R ^a,b,c  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c PremUP   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIV LILLE   (France)

Author keywords

Development; Malformation; Prenatal diagnosis; Pulmonary hypertension; Pulmonary hypoplasia; Tracheal occlusion

Indexed keywords

BOSENTAN; CORTICOSTEROID; DEXAMETHASONE; ENDOTHELIN A RECEPTOR ANTAGONIST; GLUCOCORTICOID; INOTROPIC AGENT; LUNG SURFACTANT; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; RETINOID; RETINOL; SILDENAFIL; STEROID; VASOACTIVE AGENT; VASODILATOR AGENT;

CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; ECHOGRAPHY; EMBRYO DEVELOPMENT; FETUS LUNG MATURATION; FETUS SURGERY; GENETIC POLYMORPHISM; HIGH FREQUENCY VENTILATION; HUMAN; LUNG DEVELOPMENT; LUNG HYPOPLASIA; LUNG VASCULAR RESISTANCE; LUNG VOLUME; MOLECULAR GENETICS; NEWBORN MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; THREE DIMENSIONAL IMAGING; TRACHEA OBSTRUCTION; TRANSGENIC MOUSE;

EID: 53649110274     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339808785161341     Document Type: Review

References (234)

1. Skari H, Bjornland K, Haugen G, Egeland T, Emblem R. Congenital diaphragmatic hernia: a meta-analysis of mortality factors. J Pediatr Surg 2000; 35: 1187-97.
2. Harrison MR, Bjordal RI, Langmark F, Knutrud O. Congenital diaphragmatic hernia: the hidden mortality. J Pediatr Surg 1978; 13: 227-30.
3. Stege G, Fenton A, Jaffray B. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. Pediatrics 2003; 112: 532-5.
4. Slavotinek AM. Fryns syndrome: a review of the phenotype and diagnostic guidelines. Am J Med Genet A 2004; 124: 427-33.
5. Enns GM, Cox VA, Goldstein RB, Gibbs DL, Harrison MR, Golabiv M. Congenital diaphragmatic defects and associated syndromes, malformations, and chromosome anomalies: a retrospective study of 60 patients and literature review. Am J Med Genet 1998; 79: 215-25.
6. Torfs CP, Curry CJ, Bateson TF, Honore LH. A population-based study of congenital diaphragmatic hernia. Teratology 1992; 46: 555-65.
7. Yang W, Carmichael SL, Harris JA, Shaw GM. Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol 2006; 76: 170-4.
8. Puri P, Wester T. Historical aspects of congenital diaphragmatic hernia. Pediatr Surg Int 1997; 12: 95-100.
9. Golombek SG. The history of congenital diaphragmatic hernia from 1850s to present. J Perinatol 2002; 22: 242-6.
10. Campanale RP, Rowland RH. Hypoplasia of the lung associated with diaphragmatic hernia. Ann Surg 1955; 142: 176-89.
11. Murdock AI, Burrington JB, Swyer PR. Alveolar to arterial oxygen tension difference and venous admixture in newly born infants with congenital diaphragmatic herniation through the foramen of Bochdalek. Biol Neonate 1971; 17: 161-72.
12. De Lorimier AA, Tierney DF, Parker HF. Hypoplastic lungs in the fetal lambs with surgically produced congenital diaphragmatic hernia. Surgery 1967; 19: 131-40.
13. Kent GM, Olley PM, Creighton RE, et al. Hemodynamic and pulmonary changes following surgical creation of a diaphragmatic hernia in fetal lambs. Surgery 1972; 72: 427-33.
14. Harrison MR, Bressack MA, Churg AM, de Lorimier AA. Correction of congenital diaphragmatic hernia in utero. II. Simulated correction permits fetal lung growth with survival at birth. Surgery 1980; 88: 260-8.
15. Soper RT, Pringle KC, Scofield JC. Creation and repair of diaphragmatic hernia in the fetal lamb: techniques and survival. J Pediatr Surg 1984; 19: 33-40.
16. Fauza DO, Tannuri U, Ayoub AA, Capelozzi VL, Saldiva PH, Maksoud JG. Surgically produced congenital diaphragmatic hernia in fetal rabbits. J Pediatr Surg 1994; 29: 882-6.
17. Wu J, Yamamoto H, Gratacos E, et al. Lung development following diaphragmatic hernia in the fetal rabbit. Hum Reprod 2000; 15: 2483-8.
18. Harrison MR, Anderson J, Rosen MA, Ross NA, Hendrickx AG. Fetal surgery in the primate I. Anesthetic, surgical, and tocolytic management to maximize fetal-neonatal survival. J Pediatr Surg 1982; 17: 115-22.
19. Anderson DH. Incidence of congenital diaphragmatic hernia in the young of rats bred on a diet deficient in vitamin A. Am J Dis Child 1941; 62: 888-9.
20. Greer JJ, Allan DW, Babiuk RP, Lemke RP. Recent advances in understanding the pathogenesis of nitrofen-induced congenital diaphragmatic hernia. Pediatr Pulmonol 2000; 29: 394-9.
21. Wilson JG, Warkany J. Cardiac and aortic arch anomalies in the offspring of vitamin A deficient rats correlated with similar human anomalies. Pediatrics 1950; 5: 708-25.
22. Wilson JG, Roth CB, Warkany J. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 1953; 92: 189-217.
23. Ross SA, McCaffery PJ, Drager UC, De Luca LM. Retinoids in embryonal development. Physiol Rev 2000; 80: 1021-54.
24. Iritani, I. Experimental study on embryogenesis of congenital diaphragmatic hernia. Anat Embryol (Berl) 1984; 169: 133-9.
25. Acosta JM, Chai Y, Meara JG, Bringas P Jr, Anderson KD, Warburton D. Prenatal exposure to nitrofen induces Fryns phenotype in mice. Ann Plast Surg 2001; 46: 635-40.
26. Tenbrinck R, Tibboel D, Gaillard JL, et al. Experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 1990; 25: 426-9.
27. Losada A, Xia H, Migliazza L, Diez-Pardo JA, Santisteban P, Tovar JA. Lung hypoplasia caused by nitrofen is mediated by down-regulation of thyroid transcription factor TTF-1. Pediatr Surg Int 1999; 15: 188-91.
28. Ohkawa H, Matsumoto M, Hori T, Kashiwa H. Familial congenital diaphragmatic hernia in the pig--studies on pathology and heredity. Eur J Pediatr Surg 1993; 3: 67-71.
29. Ackerman KG, Greer JJ. Development of the diaphragm and genetic mouse models of diaphragmatic defects. Am J Med Genet C Semin Med Genet 2007;145:109-16.
30. Birchmeier C, Brohman H. Genes that control the development of migrating muscle precursor cells. Curr Opin Cell Biol 2000;12: 725-30.
31. Fisher JC, Bodenstein L. Computer simulation analysis of normal and abnormal development of the mammalian diaphragm. Theor Biol Med Model 2006; 3: 9.
32. Babiuk RP, Zhang W, Clugston R, Allan DW, Greer JJ. Embryological origins and development of the rat diaphragm. J Comp Neurol 2003; 455: 477-87.
33. Allan DW, Greer JJ. Pathogenesis of nitrofen-induced congenital diaphragmatic hernia in fetal rats. J Appl Physiol 1997; 83: 338-47.
34. Greer JJ, Cote D, Allan DW, et al. Structure of the primordial diaphragm and defects associated with nitrofen-induced CDH. J Appl Physiol 2000; 89: 2123-9.
35. Keijzer R, Liu J, Deimling J, Tibboel D, Post M. Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia. Am J Pathol 2000; 156: 1299-306.
36. Babiuk RP, Greer JJ. Diaphragm defects occur in a CDH hernia model independently of myogenesis and lung formation. Am J Physiol Lung Cell Mol Physiol 2002; 283: L1310-4.
37. Mendelsohn C, Lohnes D, Decimo D, et al. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 1994; 120: 2749-71.
38. Major D, Cadenas M, Fournier L, Leclerc S, Lefebvre M, Cloutier R. Retinol status of newborn infants with congenital diaphragmatic hernia. Pediatr Surg Int 1998; 13: 547-9.
39. Kawaguchi R, Yu J, Honda J, et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007; 315: 820-5.
40. Pasutto F, Sticht H, Hammersen G, et al. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 2007; 80: 550-60.
41. Mey J, Babiuk RP, Clugston R, Zhang W, Greer JJ. Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents. Am J Pathol 2003; 162: 673-9.
42. Chen MH, MacGowan A, Ward S, Bavik C, Greer JJ. The activation of the retinoic acid response element is inhibited in an animal model of congenital diaphragmatic hernia. Biol Neonate 2003; 83: 157-61.
43. Thébaud B, Tibboel D, Rambaud C, et al. Vitamin A decreases the incidence and severity of nitrofen-induced congenital diaphragmatic hernia in rats. Am J Physiol 1999; 277: L423-9.
44. Babiuk RP, Thébaud B, Greer JJ. Reductions in the incidence of nitrofen-induced diaphragmatic hernia by vitamin A and retinoic acid. Am J Physiol Lung Cell Mol Physiol 2004; 286: L970-3.
45. Kreidberg JA, Sariola H, Loring JM, et al. WT-1 is required for early kidney development. Cell 1993; 74: 679-91.
46. You LR, Takamoto N, Yu CT, et al. Mouse lacking COUP-TFII as an animal model of Bochdalek-type congenital diaphragmatic hernia Proc Natl Acad Sci USA 2005; 10: 16351-6.
47. Kliewer SA, Umesono K, Heyman RA, Mangelsdorf DJ, Dyck JA, Evans RM. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 1992; 89: 1448-52.
48. Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 2003; 278: 14387-93.
49. Mäki JM, Sormunen R, Lippo S, Kaarteenaho-Wiik R, Soininen R, Myllyharju J. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 2005; 167: 927-36.
50. Ackerman KG, Herron BJ, Vargas SO, et al. Fog2 is required for normal diaphragm and lung development in mice and humans. PLoS Genet 2005; 1: e10.
51. Jay PY, Bielinska M, Erlich JM, et al. Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects. Dev Biol 2007; 301: 602-14.
52. Yuan W, Rao Y, Babiuk RP, Greer JJ, Wu JY, Ornitz DM. A genetic model for a central (septum transversum) congenital diaphragmatic hernia in mice lacking Slit3. Proc Natl Acad Sci USA 2003; 100: 5217-22.
53. Klaassens M, van Dooren M, Eussen HJ, et al. Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization. Am J Hum Genet 2005; 76: 877-82.
54. Kantarci S, Casavant D, Prada C, et al. Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome. Am J Med Genet A 2006; 140: 17-23.
55. Lopez I, Bafalliu JA, Bernabe MC, Garcia F, Costa M, Guillen-Navarro E. Prenatal diagnosis of de novo deletions of 8p23.1 or 15q26.1 in two fetuses with diaphragmatic hernia and congenital heart defects. Prenat Diagn 2006; 26: 577-80.
56. Slavotinek AM, Moshrefi A, Davis R, et al. Array comparative genomic hybridization in patients with congenital diaphragmatic hernia: mapping of four CDH-critical regions and sequencing of candidate genes at 15q26.1-15q26.2. Eur J Hum Genet 2006; 14: 999-1008.
57. Rathkolb B, Fuchs E, Kolb HJ, et al. Large-scale N-ethyl-N-nitrosourea mutagenesis of mice-from phenotypes to genes. Exp Physiol 2000; 85: 635-44.
58. Ackerman KG, Herron BJ, Vargas SO, et al. Fog2 is required for normal diaphragm and lung development in mice and humans. PLoS Genet 2005; 1: 58-65.
59. Ackerman KG, Wang J, Luo L, Fujiwara Y, Orkin SH, Beier DR. Gata4 is necessary for normal pulmonary lobar development. Am J Respir Cell Mol Biol 2007; 36: 391-7.
60. Crispino JD, Lodish MB, Thurberg BL, et al. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev 2001; 15: 839-44.
61. Huggins GS, Bacani CJ, Boltax J, Aikawa R, Leiden JM. Friend of GATA 2 physically interacts with chicken ovalbumin upstream promoter-TF2 (COUP-TF2) and COUP-TF3 and represses COUP-TF2-dependent activation of the atrial natriuretic factor promoter. J Biol Chem 2001; 276: 28029-36.
62. Clugston RD, Klattig J, Englert C, et al. Teratogen-induced, dietary and genetic models of congenital diaphragmatic hernia share a common mechanism of pathogenesis. Am J Pathol 2006; 169: 1541-9.
63. Whitsett JA, Wert SE, Trapnell BC. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 2004; 13 Spec: R207-15.
64. Areechon W, Reid L. Hypoplasia of lung with congenital diaphragmatic hernia. Br Med J 1963; 5325: 230-233.
65. Teramoto H, Yoneda A, Puri P. Gene expression of fibroblast growth factors 10 and 7 is downregulated in the lung of nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 2003; 38: 1021-4.
66. Unger S, Copland I, Tibboel D, Post M. Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia. Am J Pathol 2003; 162: 547-55.
67. Takayasu H, Nakazawa N, Montedonico S, Puri P. Down-regulation of Wnt signal pathway in nitrofen-induced hypoplastic lung. J Pediatr Surg 2007; 42: 426-30.
68. Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 2006; 133: 1611-24.
69. Kitagawa M, Hislop A, Boyden EA, Reid L. Lung hypoplasia in congenital diaphragmatic hernia. A quantitative study of airway, artery, and alveolar development. Br J Surg 1971; 58: 342-6.
70. George DK, Cooney TP, Chiu BK, Thurlbeck WM. Hypoplasia and immaturity of the terminal lung unit (acinus) in congenital diaphragmatic hernia. Am Rev Respir Dis 1987; 136: 947-50.
71. Nakamura Y, Yamamoto I, Fukuda S, Hashimoto T. Pulmonary acinar development in diaphragmatic hernia. Arch Pathol Lab Med 1991; 115: 372-6.
72. Bargy F, Beaudoin S, Barbet P. Fetal lung growth in congenital diaphragmatic hernia. Fetal Diagn Ther 2006; 21: 39-44.
73. Nakamura Y, Fukuda S, Hashimoto T. Pulmonary elastic fibers in normal human development and in pathological conditions. Pediatr Pathol 1990; 10: 689-706.
74. Boucherat O, Benachi A, Barlier-Mur AM, et al. Decreased lung fibroblast growth factor 18 and elastin in human congenital diaphragmatic hernia and animal models. Am J Respir Crit Care Med 2007; 175: 1066-77.
75. Joyce BJ, Wallace MJ, Pierce RA, Harding R, Hooper SB. Sustained changes in lung expansion alter tropoelastin mRNA levels and elastin content in fetal sheep lungs. Am J Physiol Lung Cell Mol Physiol 2003; 284: L643-9.
76. Boland R, Joyce BJ, Wallace MJ, et al. Cortisol enhances structural maturation of the hypoplastic fetal lung in sheep. J Physiol 2004; 554: 505-17.
77. Mychaliska GB, Officer SM, Heintz CK, Starcher BC, Pierce RA. Pulmonary elastin expression is decreased in the nitrofen-induced rat model of congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 666-71.
78. Chailley-Heu B, Boucherat O, Barlier-Mur AM, Bourbon JR. FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts. Am J Physiol Lung Cell Mol Physiol 2005; 288: L43-51.
79. Tenbrinck R, Gaillard JL, Tibboel D, Kluth D, Lachmann B, Molenaar JC. Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 1992; 27: 862-5.
80. Shehata SM, Tibboel D, Sharma HS, Mooi WJ. Impaired structural remodelling of pulmonary arteries in newborns with congenital diaphragmatic hernia: a histological study of 29 cases. J Pathol 1999; 189: 112-8.
81. Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 1258-61.
82. de Lagausie P, de Buys-Roessingh A, Ferkdadji L, et al. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 2005; 205: 112-8.
83. Solari V, Piotrowska AP, Puri P. Expression of heme oxygenase-1 and endothelial nitric oxide synthase in the lung of newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. J Pediatr Surg 2003; 38: 808-13.
84. Shehata SM, Sharma HS, Mooi WJ, Tibboel D. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase. Cell Biochem Biophys 2006; 44: 147-55.
85. Okazaki T, Sharma HS, McCune SK, Tibboel D. Pulmonary vascular balance in congenital diaphragmatic hernia: enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction. J Pediatr Surg 1998; 33: 81-4.
86. North AJ, Moya FR, Mysore MR, et al. Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia. Am J Respir Cell Mol Biol 1995; 13: 676-82.
87. Karamanoukian HL, Peay T, Love JE, et al. Abdel-Rahman E, Dandonna P, Azizkhan RG, Glick PL. Decreased pulmonary nitric oxide synthase activity in the rat model of congenital diaphragmatic hernia. J Pediatr Surg 1996; 31: 1016-9.
88. Bos AP, Sluiter W, Tenbrinck R, Kraak-Slee R, Tibboel D. Angiotensin-converting enzyme activity is increased in lungs of rats with pulmonary hypoplasia and congenital diaphragmatic hernia. Exp Lung Res 1995; 21: 41-50.
89. Zeng X, Wert SE, Federici R, Peters KG, Whitsett JA. VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn 1998; 211: 215-27.
90. Yamamoto H, Yun EJ, Gerber HP, Ferrara N, Whitsett JA, Vu TH. Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol 2007; 308: 44-53.
91. Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2003; 284: L508-17.
92. Grover TR, Parker TA, Balasubramaniam V, Markham NE, Abman SH. Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2005; 288: L648-54.
93. Shehata SM, Mooi WJ, Okazaki T, El-Banna I, Sharma HS, Tibboel D. Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax 1999; 54: 427-31.
94. Chelly N, Henrion A, Pinteur C, Chailley-Heu B, Bourbon JR. Role of keratinocyte growth factor in the control of surfactant synthesis by fetal lung mesenchyme. Endocrinology 2001; 142: 1814-9.
95. Torday JS, Sun H, Wang L, Torres E, Sunday ME, Rubin LP. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol 2002; 282: L405-10.
96. Kirwin SM, Bhandari V, Dimatteo D, et al. Leptin enhances lung maturity in the fetal rat. Pediatr Res 2006; 60: 200-4.
97. Dammann CE, Nielsen HC, Carraway KL 3rd. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 2003; 167: 1711-6.
98. Wigglesworth JS, Desai R, Guerrini P. Fetal lung hypoplasia: biochemical and structural variations and their possible significance. Arch Dis Child 1981; 56: 606-15.
99. Glick PL, Stannard VA, Leach CL, et al. Pathophysiology of congenital diaphragmatic hernia II: the fetal lamb CDH model is surfactant deficient. J Pediatr Surg 1992; 27: 382-7.
100. Suen HC, Catlin EA, Ryan DP, Wain JC, Donahoe PK. Biochemical immaturity of lungs in congenital diaphragmatic hernia. J Pediatr Surg 1993; 28: 471-5.
101. Mysore MR, Margraf LR, Jaramillo MA, et al. Surfactant protein A is decreased in a rat model of congenital diaphragmatic hernia. Am J Respir Crit Care Med 1998; 157: 654-7.
102. Thébaud B, Barlier-Mur AM, Chailley-Heu B, et al. Restoring effects of vitamin A on surfactant synthesis in nitrofen-induced congenital diaphragmatic hernia in rats. Am J Respir Crit Care Med 2001; 164: 1083-9.
103. Benachi A, Chailley-Heu B, Barlier-Mur AM, Dumez Y, Bourbon J. Expression of surfactant proteins and thyroid transcription factor 1 in an ovine model of congenital diaphragmatic hernia. J Pediatr Surg 2002; 37: 1393-8.
104. Van Tuyl M, Blommaart PE, Keijzer R, et al. Pulmonary surfactant protein A, B, and C mRNA and protein expression in the nitrofen-induced congenital diaphragmatic hernia rat model. Pediatr Res 2003; 54: 641-52.
105. Chapin CJ, Ertsey R, Yoshizawa J, et al. Congenital diaphragmatic hernia, tracheal occlusion, thyroid transcription factor-1, and fetal pulmonary epithelial maturation. Am J Physiol Lung Cell Mol Physiol 2005; 289: L44-52.
106. Davey MG, Biard JM, Robinson L, et al. Surfactant protein expression is increased in the ipsilateral but not contralateral lungs of fetal sheep with left-sided diaphragmatic hernia. Pediatr Pulmonol 2005; 39: 359-67.
107. Wilcox DT, Glick PL, Karamanoukian HL, Azizkhan RG, Holm BA. Pathophysiology of congenital diaphragmatic hernia. XII: Amniotic fluid lecithin/sphingomyelin ratio and phosphatidylglycerol concentrations do not predict surfactant status in congenital diaphragmatic hernia. J Pediatr Surg 1995; 30: 410-2.
108. Cogo PE, Zimmermann LJ, Rosso F, et al. Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002; 166: 154-8.
109. Cogo PE, Zimmermann LJ, Meneghini L, et al. Pulmonary surfactant disaturated-phosphatidylcholine (DSPC) turnover and pool size in newborn infants with congenital diaphragmatic hernia (CDH). Pediatr Res 2003; 54: 653-8.
110. IJsselstijn H, Zimmermann LJ, Bunt JE, de Jongste JC, Tibboel D. Prospective evaluation of surfactant composition in bronchoalveolar lavage fluid of infants with congenital diaphragmatic hernia and of age-matched controls. Crit Care Med 1998; 26: 573-80.
111. Berk C, Grundy M. 'High risk' lecithin/sphingomyelin ratios associated with neonatal diaphragmatic hernia. Case reports. Br J Obstet Gynaecol 1982; 89: 250-1.
112. Moya FR, Thomas VL, Romaguera J, et al. Fetal lung maturation in congenital diaphragmatic hernia. Am J Obstet Gynecol 1995; 173: 1401-5.
113. Sullivan KM, Hawgood S, Flake AW, Harrison MR, Adzick NS. Amniotic fluid phospholipid analysis in the fetus with congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 1020-3.
114. Boucherat O, Benachi A, Chailley-Heu B, et al. Surfactant maturation is not delayed in human fetuses with diaphragmatic hernia. PLoS Med 2007; 4: e237.
115. Lally KP, Lally PA, Langham MR, et al. Congenital Diaphragmatic Hernia Study Group. Surfactant does not improve survival rate in preterm infants with congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 829-33.
116. Harrison MR, Adzick NS, Flake AW, et al. Correction of congenital diaphragmatic hernia in utero: VI. Hard-earned lessons. J Pediatr 1993; 28: 1411-7.
117. Harrison MR, Adzick NS, Bullard KM, et al. Correction of congenital diaphragmatic hernia in utero VII: a prospective trial. J Pediatr Surg 1997; 32: 1637-42.
118. Sharland GK, Lockhart SM, Heward AJ, Allan LD. Prognosis in fetal diaphragmatic hernia. Am J Obstet Gynecol 1992; 166: 9-13.
119. Thébaud B, Azancot A, de Lagausie P, et al. Congenital diaphragmatic hernia: antenatal prognostic factors. Does cardiac ventricular disproportion in utero predict outcome and pulmonary hypoplasia? Intensive Care Med 1997; 23: 10062-9.
120. Hatch El Jr, Kendall J, Blumhagen J. Stomach position as an in utero predictor of neonatal outcome in left-sided diaphragmatic hernia. J Pediatr Surg 1992; 27: 778-9.
121. Dommergues M, Louis-Sylvestre C, Mandelbrot L, et al. Congenital diaphragmatic hernia: can prenatal ultrasonography predict outcome? Am J Obstet Gynecol 1996; 174: 1377-81.
122. Balhmann F, Merz E, Hallermann C, Stopfkuchen H, Kramer W, Hofmann M. Congenital diaphragmatic hernia: ultrasonic measurement of fetal lungs to predict pulmonary hypoplasia. Ultrasound Obstet Gynecol 1999; 14: 162-8.
123. Mahieu-Caputo D, Sonigo P, Dommergues M, et al. Fetal lung volume measurements by magnetic resonance imaging in congenital diaphragmatic hernia. BJOG 2001; 108: 863-8.
124. Gorincour G, Bouvenot J, Mourot MG, et al. Groupe Radiopédiatrique de Recherche en Imagerie Foetale (GRRIF). Prenatal prognosis of congenital diaphragmatic hernia using magnetic resonance imaging measurement of fetal lung volume. Ultrasound Obstet Gynecol 2005; 26: 738-44.
125. Mektus AP, Filly RA, Stringer MD, Harrison MR, Adzick NS. Sonographic predictors of survival in fetal diaphragmatic hernia. J Pediatr Surg 1996; 31: 148-52.
126. Heling KS, Wauer RR, Hammer H, Bollmann R, Chaoui R. Reliabilty of the lung-to-head ratio in predicting outcome and neonatal ventilation parameters in fetus with congenital diaphragmatic hernia. Ultrasound Obstet Gynecol 2005; 25: 112-8.
127. Jani J, Keller RL, Benachi A, et al. Prenatal prediction of survival in isolated left-sided diaphragmatic hernia. Ultrasound Obstet Gynecol 2006; 27: 18-22.
128. Jani J, Benachi A, Nicolaides KH, et al. Prenatal prediction of neonatal morbidity in congenital diaphragmatic hernia: a multicenter study. (submitted)
129. Jani J, Nicolaides KH, Keller RL, et al. Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia. Ultrasound Obstet Gynecol 2007; 30: 67-71.
130. Ruano R, Benachi A, Joubin L, Aubry MC, Thalabard JC, Dumez Y, Dommergues M. Three-dimensional ultrasonographic assessment of fetal lung volume as prognostic factor in isolated congenital diaphragmatic hernia. BJOG 2004; 111: 423-9.
131. Jani JC, Cannie M, Peralta CF, Deprest JA, Nicolaides KH, Dymarkowski S. Lung volumes in fetuses with congenital diaphragmatic hernia: comparison of 3D US and MR imaging assessments. Radiology 2007; 244: 575-82.
132. Rypens F, Metens T, Rocourt N, et al. Fetal lung volume: estimation at MR imaging-initial results. Radiology 2001; 219: 236-41.
133. Chaoui R, Taddei F, Rizzo G, Bast C, Lenz F, Bollmann R. Doppler echocardiography of the main stems of the pulmonary arteries in the normal human fetus. Ultrasound Obstet Gynecol 1998; 11: 173-9.
134. Mitchell JM, Roberts AB, Lee A. Doppler waveforms from the pulmonary arterial system in normal fetuses and those with pulmonary hypoplasia. Ultrasound Obstet Gynecol. 1998; 11: 167-72.
135. Mahieu-Caputo D, Aubry MC, El Sayed M, Joubin L, Thalabard JC, Dommergues M. Evaluation of fetal pulmonary vasculature by power Doppler imaging in congenital diaphragmatic hernia. J Ultrasound Med 2004; 23: 1011-7.
136. Hernandez-Andrade E, Jansson T, Ley D, et al. Validation of fractional moving blood volume measurement with power Doppler ultrasound in an experimental sheep model. Ultrasound Obstet Gynecol 2004; 23: 363-8.
137. Ruano R, Aubry MC, Barthe B, Mitanchez D, Dumez Y, Benachi A. Quantitative analysis of fetal pulmonary vasculature by 3-dimensional power Doppler ultrasonography in isolated congenital diaphragmatic hernia. Am J Obstet Gynecol 2006; 195: 1720-8.
138. Harrison MR, Adzick NS, Longaker MT, et al. Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med 1990; 322: 1582-4.
139. Jost A, Policard A. Contribution expérimentale a l'étude du développement prénatal du poumon chez le lapin. Arch. Anat Micr 1948; 37: 323-32.
140. Alcorn D, Adamson TM, Lambert TF, Maloney JE, Ritchie BC, Robinson PM. Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. J Anat 1977; 123: 649-60.
141. Moessinger AC, Harding R, Adamson TM, Singh M, Kiu GT. Role of lung fluid volume in growth and maturation of the fetal sheep lung. J Clin Invest 1990; 86: 1270-7.
142. Wilson JM, DiFiore JW, Peters CA. Experimental fetal tracheal ligation prevents the pulmonary hypoplasia associated with fetal nephrectomy: possible application for congenital diaphragmatic hernia. J Pediatr Surg 1993; 28: 1433-9.
143. DiFiore JW, Fauza DO, Slavin R, Peters CA, Fackler JC, Wilson JM. Experimental fetal tracheal ligation reverses the structural and physiological effects of pulmonary hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 248-56.
144. Hedrick MH, Estes JM, Sullivan KM, et al. Plug the lung until it grows (PLUG): a new method to treat congenital diaphragmatic hernia in utero. J Pediatr Surg 1994; 29: 612-7.
145. Davey MG, Danzer E, Schwarz U, Adzick NS, Flake AW, Hedrick HL. Prenatal glucocorticoids and exogenous surfactant therapy improve respiratory function in lambs with severe diaphragmatic hernia following fetal tracheal occlusion. Pediatr Res 2006; 60: 131-5.
146. Harrison MR, Sydorak RM, Farrell JA, et al. Fetoscopic temporary tracheal occlusion for congenital diaphragmatic hernia: preclude to a randomized controlled trial. J Pediatr Surg 2003; 38: 1012-20.
147. Harrison MR, Albanese CT, Hawgood SB, et al. Fetoscopic temporary tracheal occlusion by means of detachable balloon for congenital diaphragmatic hernia. Am J Obstet Gynecol 2001; 185: 730-3.
148. Jani J, Gratacos E, Greenough A, et al. Percutaneous fetal endoscopic tracheal occlusion (FETO) for severe left-sided congenital diaphragmatic hernia. Clin Obstet Gynecol 2005; 48: 910-22.
149. Benachi A, Chailley-Heu B, Delezoide AL, et al. Lung growth and maturation after tracheal occlusion in diaphragmatic hernia. Am J Respir Crit Care Med 1998; 157: 921-7.
150. Benachi A, Delezoide AL, Chailley-Heu B, Preece M, Bourbon JR, Ryder T. Ultrastructural evaluation of lung maturation in a sheep model of diaphragmatic hernia and tracheal occlusion. Am J Respir Cell Mol Biol 1999; 20: 805-12.
151. Nelson SM, Hajivassiliou CA, Haddock G, et al. Rescue of the hypoplastic lung by prenatal cyclical strain. Am J Respir Crit Care Med 2005; 171: 1395-402.
152. Flageole H, Evrard V, Piedboeuf B, Laberge JM, Lerut TE, Deprest JA. The plug-unplug sequence: an important step to achieve type II pneumocyte maturation in the foetal lamb model. J Pediatr Surg 1998; 33: 299-303.
153. Papadakis K, Luks FI, De Paepe ME, Piasecki GJ, Wesselhoeft CW Jr. Fetal lung growth after tracheal ligation is not solely a pressure phenomenon. J Pediatr Surg 1997; 32: 347-51.
154. McCabe AJ, Carlino U, Holm BA, Glick PL. Upregulation of keratinocyte growth factor in the tracheal ligation lamb model of congenital diaphragmatic hernia. J Pediatr Surg 2001; 36: 128-32.
155. Hara A, Chapin CJ, Ertsey R, Kitterman JA. Changes in fetal lung distension alter expression of vascular endothelial growth factor and its isoforms in developing rat lung. Pediatr Res 2005; 58: 30-7.
156. Hooper SB, Han VK, Harding R. Changes in lung expansion alter pulmonary DNA synthesis and IGF-II gene expression in fetal sheep. Am J Physiol 1993; 265: L403-9.
157. Wallace MJ, Thiel AM, Lines AM, Polglase GR, Sozo F, Hooper SB. Role of platelet-derived growth factor-B, vascular endothelial growth factor, insulin-like growth factor-II, mitogen-activated protein kinase and transforming growth factor-beta1 in expansion-induced lung growth in fetal sheep. Reprod Fertil Dev 2006; 18: 655-65.
158. Sozo F, Wallace MJ, Zahra VA, Filby CE, Hooper SB. Gene expression profiling during increased fetal lung expansion identifies genes likely to regulate development of the distal airways. Physiol Genomics 2006; 24: 105-13.
159. Benachi A, Dommergues M, Delezoide AL, Bourbon J, Dumez Y, Brunnelle F. Tracheal obstruction in experimental diaphragmatic hernia: an endoscopic approach in the fetal lamb. Prenat Diagn 1997; 17: 629-34.
160. Bratu I, Flageole H, Laberge JM, Chen MF, Piedboeuf B. Pulmonary structural maturation and pulmonary artery remodeling after reversible fetal ovine tracheal occlusion in diaphragmatic hernia. J Pediatr Surg 2001; 36: 739-44.
161. Roubliova X, Verbeken E, Wu J, Vaast P, Jani J, Deprest JA. Effect of tracheal occlusion on peripheric pulmonary vessel muscularisation in a foetal rabbit model of congenital diaphragmatic hernia. Am G Obstet Gynecol 2004; 191: 830-6.
162. Sylvester KG, Rasanen J, Kitano Y, Flake AW, Crombleholme TM, Adzick NS. Tracheal occlusion reverses the high impedance to flow in the foetal pulmonary circulation and it normalizes its physiological response to oxygen at full term. J Pediatr Surg 1998; 33: 1071-75.
163. Wu J, Ge X, Verbeken E, Gratacós E, Yesildaglar N, Deprest JA. In utero tracheal occlusion at different gestational age has different pulmonary effects in a rabbit model of diaphragmatic hernia. J Pediatr Surg 2000; 37: 11-7.
164. Harrison MR, Keller RL, Hawgood SB, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 2003; 349: 1916-24
165. Deprest J, Gratacos E, Nicolaides KH; FETO Task Group. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. Ultrasound Obstet Gynecol 2004; 24: 121-6.
166. Suen HC, Losty P, Donahoe PK, Schnitzer JJ. Combined antenatal thyrotropin-releasing hormone and low-dose glucocorticoid therapy improves the pulmonary biochemical immaturity in congenital diaphragmatic hernia. J Pediatr Surg 1994; 29: 359-63.
167. Guarino N, Oue T, Shima H, Puri P. Antenatal dexamethasone enhances surfactant protein synthesis in the hypoplastic lung of nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 2000; 35: 1468-73.
168. Losty PD, Suen HC, Manganaro TF, Donahoe PK, Schnitzer JJ. Prenatal hormonal therapy improves pulmonary compliance in the nitrofen-induced CDH rat model. J Pediatr Surg 1995; 30: 420-6.
169. Losty PD, Pacheco BA, Manganaro TF, Donahoe PK, Jones RC, Schnitzer JJ. Prenatal hormonal therapy improves pulmonary morphology in rats with congenital diaphragmatic hernia. J Surg Res 1996; 65: 42-52.
170. Oue T, Shima H, Taira Y, Puri P. Administration of antenatal glucocorticoids upregulates peptide growth factor gene expression in nitrofen-induced congenital diaphragmatic hernia in rats. J Pediatr Surg 2000; 35: 109-12.
171. Taira Y, Shima H, Miyazaki E, Ohshiro K, Puri P. Antenatal dexamethasone administration inhibits smooth-muscle-cell DNA synthesis in pulmonary-arterial media in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatr Surg Int 2000; 16: 414-6.
172. Tannuri U, Maksoud-Filho JG, Santos MM, Tannuri AC, Rodrigues CJ, Rodrigues AJ Jr. The effects of prenatal intraamniotic surfactant or dexamethasone administration on lung development are comparable to changes induced by tracheal ligation in an animal model of congenital diaphragmatic hernia. J Pediatr Surg 1998; 33: 1198-205.
173. Schnitzer JJ, Hedrick HL, Pacheco BA, et al. Prenatal glucocorticoid therapy reverses pulmonary immaturity in congenital diaphragmatic hernia in fetal sheep. Ann Surg 1996; 224: 430-7.
174. Hedrick HL, Kaban JM, Pacheco BA, et al. Prenatal glucocorticoids improve pulmonary morphometrics in fetal sheep with congenital diaphragmatic hernia. J Pediatr Surg 1997; 32: 217-21.
175. Davey M, Shegu S, Danzer E, Ruchelli E, Adzick S, Flake A, Hedrick HL. Pulmonary arteriole muscularization in lambs with diaphragmatic hernia after combined tracheal occlusion/glucocorticoid therapy. Am J Obstet Gynecol 2007; 197: 381.e1-7.
176. Kapur P, Holm BA, Irish MS, Sokolowski J, Patel A, Glick PL. Lung physiological and metabolic changes in lambs with congenital diaphragmatic hernia after administration of prenatal maternal corticosteroids. J Pediatr Surg 1999; 34: 354-6.
177. Lally KP, Bagolan P, Hosie S, et al. Corticosteroids for fetuses with congenital diaphragmatic hernia: can we show benefit? J Pediatr Surg 2006; 41: 668-74.
178. National Institute of Health Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses- National Institute of Health Consensus Development Conference Statement. August 17-18, 2000. Obstet Gynecol 2001; 98: 144-50.
179. Bratu I, Flageole H, Laberge JM, et al. Surfactant levels after reversible tracheal occlusion and prenatal steroids in experimental diaphragmatic hernia. J Pediatr Surg 2001; 36: 122-7.
180. Davey MG, Danzer E, Schwarz U, et al. Prenatal glucocorticoids improve lung morphology and partially restores surfactant mRNA expression in lambs with diaphragmatic hernia undergoing fetal tracheal occlusion. Pediatr Pulmonol 2006; 41: 1188-96
181. Montedonico S, Nakazawa N, Puri P. Retinoic acid rescues lung hypoplasia in nitrofen-induced hypoplastic foetal rat lung explants. Pediatr Surg Int 2006; 22: 2-8.
182. Losada A, Tovar JA, Xia HM, Diez-Pardo JA, Santisteban P. Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glucocorticoids. Endocrinology 2000; 141: 2166-73.
183. Gonzalez-Reyes S, Martinez L, Martinez-Calonge W, Fernandez-Dumont V, Tovar JA. Effects of antioxidant vitamins on molecular regulators involved in lung hypoplasia induced by nitrofen. J Pediatr Surg 2006; 41: 1446-52.
184. Gonzalez-Reyes S, Martinez L, Martinez-Calonge W, Fernandez-Dumont V, Tovar JA. Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes. Biol Neonate 2006; 90: 9-16.
185. Nakazawa N, Montedonico S, Takayasu H, Paradisi F, Puri P. Disturbance of retinol transportation causes nitrofen-induced hypoplastic lung. J Pediatr Surg 2007; 42: 345-9.
186. Biesalski HK, Nohr D. Importance of vitamin-A for lung function and development. Mol Aspects Med 2003; 24: 431-40.
187. Lewis NA, Holm BA, Swartz D, Sokolowski J, Rossman J, Glick PL. Antenatal vitamin A decreases ventilation-induced lung injury in the lamb model of congenital diaphragmatic hernia. Asian J Surg 2006; 29: 193-7.
188. Massaro GD, Massaro D. Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats. Am J Physiol 1996; 270: L305-10.
189. Massaro GD, Massaro D. Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 2000; 278: L955-60.
190. Rudolph AM, Heymann MA. Pulmonary circulation in fetal lambs. Pediatr Res 1972; 6: 341-7.
191. Lewis AB, Heymann MA, Rudolph AM. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 1976; 39: 536-41.
192. Teitel DF, Iwamoto H, Rudolph AM. Effects of birth related events on central blood flow patterns. Pediatr Res 1987; 22: 557-66.
193. Cassin S, Gause G, Davis T, TerRiet M, Baker R. Do inhibitors of lipooxygenase and cyclooxygenase block neonatal hypoxic pulmonary vasoconstriction? J Appl Physiol 1988; 66: 1779-84.
194. Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 1994; 93: 2141-8.
195. Abman SH, Accurso FJ. Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am J Physiol 1989; 257: H626-34.
196. Accurso FJ, Alpert B, Wilkening RB, Petersen RG, Meschia G. Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tension. Respir Physiol 1986; 63: 43-52.
197. Storme L, Rairigh RL, Parker TA, Kinsella JP, Abman SH. In vivo evidence for a myogenic response in the fetal pulmonary circulation. Pediatr Res 1999; 45: 1-7.
198. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990; 259: H1921-7
199. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995; 126: 853-64.
200. Belik J, Light RB. Effect of increased afterload on right ventricular function in newborn pigs. J Appl Physiol 1989; 66: 863-9.
201. Bohn D. Congenital diaphragmatic hernia. Am J Respir Crit Care Med 2002; 166: 911-5.
202. Geggel RL, Murphy JD, Langleben D, Crone RK, Vacanti JP, Reid LM. Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr 1985; 107: 457-64.
203. O'Toole SJ, Irish MS, Holm BA, Glick PL. Pulmonary vascular abnormalities in congenital diaphragmatic hernia. Clin Perinatol 1996; 23: 781-94.
204. Walsh M, Stork E. Persistent pulmonary hypertension of the newborn. Rational therapy bases on pathophysiology. Clin Perinatol 2001; 28: 609-27.
205. Vukcevic Z, Coppola CP, Hults C, Gosche JR. Nitrovasodilator responses in pulmonary arterioles from rats with nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 2005; 40: 1706-11.
206. Newell MA, Au-Fliegner M, Cappola CP, Gosche JR. Hypoxic pulmonary vasoconstriction is impaired in rats with nitrofen-induced congenital diaphragmatic hermia. J Pediatr surg 1998; 33: 1358-62.
207. Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 2001; 89: 67-79.
208. Bagolan P, Casaccia G, Crescenzi F, Nahom A, Trucchi A, Giorlandino C. Impact of a current treatment protocol on outcome of high-risk congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 313-8.
209. Boloker J, Bateman DA, Wung JT, Stolar CJ. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/ spontaneous respiration/elective repair. J Pediatr Surg 2002; 37: 357-66.
210. Downard CD, Jaksic T, Garza JJ, et al. Analysis of an improved survival rate for congenital diaphragmatic hernia. J Pediatr Surg 2003; 38: 729-32.
211. Finer NN, Tierney A, Etches PC, Peliowski A, Ainsworth W. Congenital diaphragmatic hernia: Developing a protocolized approach. J Pediatr Surg 1998; 33: 1331-7.
212. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent Pulmonary Hypertension of the Newborn in the Era Before Nitric Oxide: Practice Variation and Outcomes. Pediatrics 2000; 105: 14-20.
213. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database System Rev 2006; (4): CD000399.
214. Archer SL, Huang J, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1994; 91: 7583-7.
215. Larrue B, Jaillard S, Lorthioir M, et al. Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1193-200.
216. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of nitric oxide. J Pediatr 1993; 123: 103-8.
217. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol 2005; 29: 123-8.
218. Dillon PW, Cilley RE, Mauger D, Zachary C, Meier A. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 2004; 39: 307-12.
219. The neonatal inhaled nitric oxide study group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997; 99: 838-45.
220. Thébaud B, Petit T, De Lagausie P, Dall'Ava-Santucci J, Mercier JC, Dinh-Xuan AT. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia. Am J Respir Cell Mol Biol 2002; 27: 42-7.
221. Karamanoukian HL, Glick PL, Zayeck M, et al. Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics 1994; 94: 715-8.
222. Kinsella JP, Parker TA, Ivy DD, Abman SH. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr 2003; 142: 397-401.
223. Dillon PW, Cilley RE, Hudome SM, Ozkan EN, Krummel TM. Nitric oxide reversal of recurrent pulmonary hypertension and respiratory failure in an infant with CDH after successful ECMO therapy. J Pediatr Surg 1995; 30: 743-4.
224. Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation 2003; 107: 3230-35.
225. Hanson KA, Ziegler JW, Rybalkin SD, Miller JW, Abman SH, Clarke WR. Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity. Am J Physiol 1998; 275: L931-41.
226. Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 2002; 165: 1098-102.
227. Jaillard S, Larrue B, Deruelle P, Delelis A, Rakza T, Butrous G, Storme L. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb. Ann Thorac Surg 2006; 81: 935-42.
228. Noori S, Friedlich P, Wong P, Garingo A, Seri I. Cardiovascular effects of sildenafil in neonates and infants with congenital diaphragmatic hernia and pulmonary hypertension. Neonatology 2007; 91: 92-100.
229. Keller RL, Moore P, Teitel D, Hawgood S, McQuitty J, Fineman JR. Abnormal vascular tone in infants and children with lung hypoplasia: Findings from cardiac catheterization and the response to chronic therapy. Pediatr Crit Care Med 2006; 7: 589-94.
230. Bétrémieux P, Gaillot T, de la Pintière A, et al. Congenital diaphragmatic hernia: prenatal diagnosis permits immediate intensive care with high survival rate in isolated cases. A population-based study. Prenat Diagn 2004; 24: 487-93.
231. Ivy D, Le Cras T, Horan M, Abman S. Increased lung preproET-1 and decreased ETB-receptor gene expression in fetal pulmonary hypertension. Am J Physiol 1998; 274: L535-41.
232. Ivy D, Parker T, Ziegler J, et al. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997; 99: 1179-86.
233. Kavanagh M, Battistini B, Jean S, et al. Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia. Br J Pharmacol 2001; 134: 1679-88.
234. Thébaud B, de Lagausie P, Forgues D, Aigrain Y, Mercier JC, Dinh-Xuan AT. ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 2000; 278: L923-32.